Aktis Oncology Reports Financial Results and Business Highlights for the Second Quarter 2026

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. SPY
2. WBD
3. PSKY
4. NVDA
5. TSLA
6. USO
7. AMD
8. META
9. AMC
10. ACN

Go back to Aktis Oncology Reports Financial Results and Business Highlights for the Second Quarter 2026
(NASDAQ: AKTS) Delayed: 21.43 -0.45 (2.06%)
Previous Close $21.88    52 Week High $5.77 
Open $22.06    52 Week Low $1.51 
Day High $22.06    P/E N/A 
Day Low $20.75    EPS $0.00 
Volume 614,264